The packaging for the prescription drug is not child-resistant
of ConsumerAffairs
Novel Laboratories of Somerset, N.J., is recalling about 570 boxes of Zolpidem Tartrate Sublingual tablets.
The packaging for the prescription drug is not child-resistant as required by the Poison Prevention Packaging Act, posing a risk of poisoning if swallowed by children.
No incidents or injuries have been reported.
This recall involves 1.75-mg and 3.5-mg Zolpidem Tartrate sublingual (rapid dissolve) tablets from Novel Laboratories. The prescription medication is a sleep drug.
The packaging for the 1.75-mg tablets has lot number M16140A, 1.75-mg and national drug code (NDC) 43386-762-30. The packaging for the 3.5-mg tablets has lot number M16144A, 3.5-mg and national drug code (NDC) 43386-761-30.
The Zolpidem Tartrate is packaged as a single tablet in a peel-and-push blister pack inside an outer open-ended pouch with 30 pouches per box. The lot number and an expiration date of 02/2018 are printed on the bottom left of the pouches.
The NDC is printed on the top left corner of the boxes. “Gavis” is printed in blue on the center of the white boxes and pouches.
The medication, manufactured in The U.S., was sold at clinics and pharmacies nationwide, including CVS, Costco, Walgreens, Kroger, and Wegmans from March 2016, through May 2016, for about $800 per box of 30 tablets.
What to do
Consumers should immediately stop using the recalled tablets and contact Novel Laboratories for instructions to receive a full refund.
Consumers may contact Novel Laboratories toll-free at (866) 403-7592 from 9 a.m. to 5 p.m. (ET) Monday through Friday or online at www.novellabs.net for more information.